IMCD achieves US$580M operating EBITA in 2025
The results reflect a complex fiscal period marked by significant macroeconomic headwinds, including geopolitical instability, shifting tariff policies, and adverse foreign exchange movements, which hampered organic growth.
NETHERLANDS – IMCD, a global leader in the distribution and formulation of specialty chemicals and ingredients, reported robust full-year 2025 results with operating EBITA reaching €498 million (US$579.78M), reflecting resilience in a volatile market.
The figures highlight steady revenue growth to €4,779 million (US$5.57B) (+5% on a constant-currency basis) and gross profit of €1,194 million (+3% on a constant-currency basis), driven by organic expansion and strategic acquisitions despite foreign-exchange headwinds.
Revenue rose 1% year-over-year to €4,778.9 million (US$1.39B), boosted by +1% organic growth, +4% from new acquisitions, offset by -3% currency impacts.
The company’s diversified portfolio across the pharma, food, coatings, and advanced materials segments maintained a gross profit margin of around 25%, underscoring pricing discipline and value-added services, such as formulation expertise.
Operating EBITA dipped 3% on constant currency due to softer demand in industrial end-markets, but free cash flow climbed 3% to €465 million (US$541.58M), enabling shareholder returns and M&A pursuits.
The company successfully completed seven strategic acquisitions across all major regions, including Ferrer Alimentación and TECOM in Spain, and Tillmanns in Italy.
The net result fell 22% to €217.5 million (US$253.32M), influenced by higher amortization, finance costs, and one-off organizational tweaks, partially cushioned by lower taxes.
IMCD’s performance shines in food and nutrition, key for agribusiness stakeholders.
The EMEA region posted revenue of €2,078.1 million (US$2.42B) (+5% constant currency), with gross profit up 2% to €561.3 million (US$653.78M), though margins slipped to 27.0% from the acquisition mix.
Americas saw stable 22.5% margins at €282.3 million (US$328.81M) in gross profit, while APAC faced organic declines but benefited from acquisition tailwinds.
CEO Marcus Jordan emphasized disciplined execution, noting that 12 acquisitions have added scale in high-growth niches such as sustainable ingredients for clean-label foods.
Marcus Jordan, CEO: “After a good first quarter, the following quarters of 2025 were challenging amid macroeconomic conditions, tariff uncertainty, and geopolitical unrest. We saw softer demand across our regions and markets, which stalled the organic growth in our business. Despite the market challenges, I’m happy to report that we increased our free cash flow and completed seven strategic acquisitions that complement our offering to customers and suppliers.”
Free cash flow strength supports dividends and bolt-on deals, positioning IMCD for an organic recovery in 2026 amid stabilizing global trade.
With a lean cost structure and €1.2 billion (US$1.398B) gross profit trajectory, IMCD eyes mid-single-digit growth ahead. Investors cheered the cash generation, lifting shares on Euronext Amsterdam.
This milestone reinforces IMCD’s stature as a formulation partner driving innovation in edible applications worldwide.
Looking ahead to 2026, IMCD remains focused on operational excellence and digital transformation.
The company has begun implementing a proprietary AI-driven sales recommendation tool to improve cross-selling ratios.
While the near-term outlook remains clouded by global trade uncertainties, the leadership team emphasized that the underlying demand for specialty ingredients continues to grow, providing a solid foundation for long-term value creation.
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
